Jeremy Paull
About Jeremy Paull
Jeremy Paull serves as the Vice President of Development & Regulatory Affairs at Starpharma Pty Ltd, a position he has held since 2006. He has a strong academic background in pharmacology and leadership, including a PhD from Monash University and executive programs from several prestigious institutions.
Work at Starpharma
Jeremy Paull has served as Vice President of Development & Regulatory Affairs at Starpharma Pty Ltd since 2006. In this role, he oversees the development and regulatory strategies for the company's product pipeline. His tenure at Starpharma spans 18 years, during which he has contributed to advancing the company's innovative drug delivery systems and nanotechnology applications in pharmaceuticals.
Education and Expertise
Jeremy Paull holds a PhD in Pharmacology from Monash University, where he studied from 1996 to 2000. He also earned a BSc (Honours) in Pharmacology and Physiology from Monash University between 1992 and 1995. Additionally, he has completed several executive education programs, including the Executive Education Leadership Program at the University of Melbourne's Melbourne Business School and the Executive Development Program for Senior Regulatory Professionals at Northwestern University's Kellogg School of Management.
Background
Jeremy Paull's educational journey began at Camberwell High School, where he studied from 1986 to 1991. Following high school, he pursued a Bachelor of Science at Monash University, which laid the foundation for his advanced studies in pharmacology. Before joining Starpharma, he worked as a research officer at Monash University for seven months in 2000, gaining valuable experience in research and development.
Professional Development
Throughout his career, Jeremy Paull has engaged in various professional development programs. He completed the Leadership and Decision Making Program at the Australian Graduate School of Management. His commitment to continuous learning is evident in his participation in multiple leadership and strategic programs, enhancing his skills in regulatory affairs and development within the pharmaceutical industry.